e u r o p e a n j o u r n a l o f p a e d i a t r i c n e u r o l o g y 2 1 ( 2 0 1 7 ) e 1 7 0 ee 1 7 1
Official Journal of the European Paediatric Neurology Society
Abstracts of EPNS 2017 e 12th European Paediatric Neurology Society Congress, 20e24 June 2017, Lyon, France ORAL COMMUNICATIONS
OC117 Are we dealing with ADHD correctly?
Friday, June 23
pez Piso n. Secci Javier Lo on Neuropediatrı´a, Hospital Miguel Servet, Zaragoza, Spain
Parallel Sessions 10:30 e 12:15 NEURODEVELOPMENT 3 PS 15: Invited Lecture How does human cognition develop? Brain imaging studies in the first months of life Ghislaine Dehaene. France
http://dx.doi.org/10.1016/j.ejpn.2017.04.1154 OC116 Neuropsychological battery for the Attention Deficit and Hyperactivity Disorder assessment in school aged children ndez. Unity of Interdisciplinary Investigation in Health D. Herna Sciences and Education, National Autonomous University of Mexico FES Iztacala, Mexico City, Mexico Objective: Present the design of a neuropsychological battery for the detection of main cognitive deficits in school aged children with ADHD. Methods: The neuropsychological battery created for the present study consists of 13 subtests that were designed based on the main neuropsychological deficits described in recent literature regarding ADHD in school aged children and it has been applied to 10 children and adjustments have been made in its design. The tests are as follows: 1. Synkinetic movements (Motor overflow). 2. Gait. 3. Synchronized movements. 4. Delay aversion. 5. Reaction time (Go/No-go task). 6. Planning. 7. Working Memory. 8. Set- shifting. 9. Temporal processing. 10. Interference control. 11. Social Cognition. 12. Rapid naming. 13. Processing speed. Results: Until now, the battery has only been applied on a small sample to make adjustments on the application parameters, because some of the subtests are automated. Conclusion: Covering the evaluation of deficient functions in children with ADHD, the test battery is expected to make an important contribution to diagnostic evaluations, after its validation process and standardization.
http://dx.doi.org/10.1016/j.ejpn.2017.04.1155
1090-3798
Introduction: Attention deficit hyperactivity disorder (ADHD) is the most prevalent neurodevelopmental disorder. It can be either an isolated case or associated to other neurodevelopmental disorders such as intellectual disability, autism spectrum disorder and learning disorders. Like the other neurodevelopmental disorders it can be a manifestation of multiple neurological diseases, hereditary or acquired, such as cerebral tumours, traumatic brain injury, or Duchenne disease. The cases of children over six years old that were attended at the neuropediatric unit over a 13-month period are reviewed here, and the cases with ADHD are analyzed. Results: Between September 2015 and October 2016, 2406 children born before the 31-08-10 were attended, and 948 of them were diagnosed as suffering from ADHD, which is 39,4% of the schoolage children that were followed at the neuropediatric unit. They were listed as having ADHD, 38,8% of those that were evaluated at any one time due to developmental delay (65/426 born before 31-810). They were found to suffer from ADHD: 48,8% (19 out of 39) of the school-age children affected by neurofibromatosis 1, 16,1% (38/236) by cerebral palsy, 30% (3/10) by tuberous sclerosis, and 61,8% (92/149) of the school-age children by tics. And 25,11% (108/ 430) of the school-age epileptic children suffered from ADHD. Discussion: Neuropediatricians manage too many conditions which lack effective treatment, and there is a very important premise for us: “to treat the treatable”. ADHD is common in a great number of children managed at neuropediatric units, and is the only neurodevelopmental disorder with effective treatment of its nuclear symptomatology. Is it not possible for a neuropediatrician to show no interest in ADHD. We are greatly responsible for its early identification and correct treatment.
http://dx.doi.org/10.1016/j.ejpn.2017.04.1156